APOE and Alzheimer disease: • Used the ATN framework to define participants by biomarker status • Key variables differed between ATN biomarker groups: age, APOE ε4, family history, body mass index, mini mental state examination score and white matter lesions • Prediction of AD pathology improved by adding these key variables to model • Addition of established risk composite scores did not improve predictive power